Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes...
Amgen’s $4 Billion Senior Unsecured Notes Offerings
Walgreens’ US$5.2 Billion Investment in VillageMD
Sidley Austin advised Walgreens Boots Alliance on the deal, while Latham & Watkins represented VillageMD. Wilmer Cutler Pickering Hale and Dorr represented Kinnevik. Walgreens Boots Alliance signed...
SoFi Technologies’ $1.1 Billion Convertible Senior Notes Offering
Wachtell, Lipton, Rosen & Katz represented SoFi in the offering, while Latham & Watkins represented the initial purchasers. SoFi Technologies, Inc. (NASDAQ: SOFI) priced its private offering of...
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
Duolingo’s Initial Public Offering
Latham & Watkins represented Duolingo, while Skadden, Arps, Slate, Meagher & Flom advised the bookrunners on the deal. Duolingo has publicly filed a registration statement with the U.S....
Similarweb’s Initial Public Offering
Latham & Watkins advised the underwriters on the deal. Similarweb Ltd. (Similarweb) executed its initial public offering of an aggregate of 8,000,000 ordinary shares at a price...